PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11435219-0	2001	Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells.	diperoxovanadate	26-42	mitogen-activated protein kinase 14	Homo sapiens	8-11	
11435219-4	2001	Treatment of ECs with p38 MAPK inhibitors SB-203580 and SB-202190 or transient transfection with a p38 dominant negative mutant mitigated the PLD activation by DPV but not by phorbol ester.	diperoxovanadate	160-163	mitogen-activated protein kinase 14	Homo sapiens	22-25	
11435219-4	2001	Treatment of ECs with p38 MAPK inhibitors SB-203580 and SB-202190 or transient transfection with a p38 dominant negative mutant mitigated the PLD activation by DPV but not by phorbol ester.	diperoxovanadate	160-163	mitogen-activated protein kinase 14	Homo sapiens	99-102	
11435219-5	2001	SB-202190 blocked DPV-mediated p38 MAPK activity as determined by activated transcription factor-2 phosphorylation.	diperoxovanadate	18-21	mitogen-activated protein kinase 14	Homo sapiens	31-34	
11435219-7	2001	Similarly, PLD1 and PLD2 were detected in p38 immunoprecipitates from control and DPV-challenged ECs.	diperoxovanadate	82-85	mitogen-activated protein kinase 14	Homo sapiens	42-45